Gyre Therapeutics, Inc. Common Stock (GYRE)
Gyre Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies targeting neurological and neurodegenerative disorders. Utilizing advanced drug delivery platforms, Gyre aims to address unmet medical needs through novel treatments that improve patient outcomes.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 12, 2023 | $0.24 | 2023-01-13 | 2023-01-05 |
| September 20, 2022 | $1.43 | 2022-09-21 | 2022-09-06 |
| August 19, 2015 | $0.57 | 2015-08-20 | 2015-08-14 |
Dividends Summary
- Gyre Therapeutics, Inc. Common Stock has issued 3 dividend payments over the past 8 years
- The most recent dividend was paid 1016 days ago, on January 12, 2023
- The highest dividend payed out to investors during this period was $1.43 per share
- The average dividend paid during this period was $0.75 per share.
Company News
Gyre Therapeutics will present positive Phase 3 clinical trial results for Hydronidone, a novel anti-fibrotic agent targeting liver fibrosis in chronic hepatitis B, at AASLD's The Liver Meeting® 2025 in Washington D.C.
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents...